aluates Reports

$ 0.0

Automative

Global Sexually Transmitted Disease Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-30A13082

Global Sexually Transmitted Disease Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Sexually Transmitted Disease Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-30A13082

Report

December 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sexually Transmitted Disease Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sexually Transmitted Disease Therapeutics Market

Sexually transmitted diseases are infections that are passed from one person to another through sexual contact.

Market Analysis and Insights: Global Sexually Transmitted Disease Therapeutics Market

The global Sexually Transmitted Disease Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Sexually Transmitted Disease Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sexually Transmitted Disease Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sexually Transmitted Disease Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sexually Transmitted Disease Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sexually Transmitted Disease Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sexually Transmitted Disease Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Sexually Transmitted Disease Therapeutics Market Report

Report Metric	Details
Report Name	Sexually Transmitted Disease Therapeutics Market
CAGR	5%
Segment by Type	Gonorrhea Syphilis Chlamydia Trichomoniasis
Segment by Application	Hospitals Diagnostic Laboratories Research and Academic Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Roche, BD, BioMérieux, Bio-Rad, Cepheid
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sexually Transmitted Disease Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Disease Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexually Transmitted Disease Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Sexually Transmitted Disease Therapeutics Market report?

Ans: The main players in the Sexually Transmitted Disease Therapeutics Market are Abbott, Roche, BD, BioMérieux, Bio-Rad, Cepheid

What are the Application segmentation covered in the Sexually Transmitted Disease Therapeutics Market report?

Ans: The Applications covered in the Sexually Transmitted Disease Therapeutics Market report are Hospitals, Diagnostic Laboratories, Research and Academic Laboratories, Others

What are the Type segmentation covered in the Sexually Transmitted Disease Therapeutics Market report?

Ans: The Types covered in the Sexually Transmitted Disease Therapeutics Market report are Gonorrhea, Syphilis, Chlamydia, Trichomoniasis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Gonorrhea

1.2.3 Syphilis

1.2.4 Chlamydia

1.2.5 Trichomoniasis

1.3 Market by Application

1.3.1 Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Research and Academic Laboratories

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sexually Transmitted Disease Therapeutics Market Perspective (2019-2030)

2.2 Global Sexually Transmitted Disease Therapeutics Growth Trends by Region

2.2.1 Sexually Transmitted Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Sexually Transmitted Disease Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Sexually Transmitted Disease Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Sexually Transmitted Disease Therapeutics Market Dynamics

2.3.1 Sexually Transmitted Disease Therapeutics Industry Trends

2.3.2 Sexually Transmitted Disease Therapeutics Market Drivers

2.3.3 Sexually Transmitted Disease Therapeutics Market Challenges

2.3.4 Sexually Transmitted Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Sexually Transmitted Disease Therapeutics by Players

3.1.1 Global Sexually Transmitted Disease Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Sexually Transmitted Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Sexually Transmitted Disease Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Sexually Transmitted Disease Therapeutics Market Concentration Ratio

3.4.1 Global Sexually Transmitted Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease Therapeutics Revenue in 2023

3.5 Global Key Players of Sexually Transmitted Disease Therapeutics Head office and Area Served

3.6 Global Key Players of Sexually Transmitted Disease Therapeutics, Product and Application

3.7 Global Key Players of Sexually Transmitted Disease Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Disease Therapeutics Breakdown Data by Type

4.1 Global Sexually Transmitted Disease Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Type (2025-2030)

5 Sexually Transmitted Disease Therapeutics Breakdown Data by Application

5.1 Global Sexually Transmitted Disease Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Sexually Transmitted Disease Therapeutics Market Size (2019-2030)

6.2 North America Sexually Transmitted Disease Therapeutics Market Size by Type

6.2.1 North America Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

6.3 North America Sexually Transmitted Disease Therapeutics Market Size by Application

6.3.1 North America Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

6.4 North America Sexually Transmitted Disease Therapeutics Market Size by Country

6.4.1 North America Sexually Transmitted Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Sexually Transmitted Disease Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Sexually Transmitted Disease Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Sexually Transmitted Disease Therapeutics Market Size (2019-2030)

7.2 Europe Sexually Transmitted Disease Therapeutics Market Size by Type

7.2.1 Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

7.3 Europe Sexually Transmitted Disease Therapeutics Market Size by Application

7.3.1 Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

7.4 Europe Sexually Transmitted Disease Therapeutics Market Size by Country

7.4.1 Europe Sexually Transmitted Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Sexually Transmitted Disease Therapeutics Market Size (2019-2030)

8.2 China Sexually Transmitted Disease Therapeutics Market Size by Type

8.2.1 China Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024)

8.2.2 China Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030)

8.2.3 China Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

8.3 China Sexually Transmitted Disease Therapeutics Market Size by Application

8.3.1 China Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024)

8.3.2 China Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030)

8.3.3 China Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Sexually Transmitted Disease Therapeutics Market Size (2019-2030)

9.2 Asia Sexually Transmitted Disease Therapeutics Market Size by Type

9.2.1 Asia Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

9.3 Asia Sexually Transmitted Disease Therapeutics Market Size by Application

9.3.1 Asia Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

9.4 Asia Sexually Transmitted Disease Therapeutics Market Size by Region

9.4.1 Asia Sexually Transmitted Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Sexually Transmitted Disease Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Sexually Transmitted Disease Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Sexually Transmitted Disease Therapeutics Introduction

11.1.4 Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024)

11.1.5 Abbott Recent Developments

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Sexually Transmitted Disease Therapeutics Introduction

11.2.4 Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024)

11.2.5 Roche Recent Developments

11.3 BD

11.3.1 BD Company Details

11.3.2 BD Business Overview

11.3.3 BD Sexually Transmitted Disease Therapeutics Introduction

11.3.4 BD Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024)

11.3.5 BD Recent Developments

11.4 BioMérieux

11.4.1 BioMérieux Company Details

11.4.2 BioMérieux Business Overview

11.4.3 BioMérieux Sexually Transmitted Disease Therapeutics Introduction

11.4.4 BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024)

11.4.5 BioMérieux Recent Developments

11.5 Bio-Rad

11.5.1 Bio-Rad Company Details

11.5.2 Bio-Rad Business Overview

11.5.3 Bio-Rad Sexually Transmitted Disease Therapeutics Introduction

11.5.4 Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024)

11.5.5 Bio-Rad Recent Developments

11.6 Cepheid

11.6.1 Cepheid Company Details

11.6.2 Cepheid Business Overview

11.6.3 Cepheid Sexually Transmitted Disease Therapeutics Introduction

11.6.4 Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024)

11.6.5 Cepheid Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Gonorrhea

Table 3. Key Players of Syphilis

Table 4. Key Players of Chlamydia

Table 5. Key Players of Trichomoniasis

Table 6. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Sexually Transmitted Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Sexually Transmitted Disease Therapeutics Market Share by Region (2019-2024)

Table 10. Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Sexually Transmitted Disease Therapeutics Market Share by Region (2025-2030)

Table 12. Sexually Transmitted Disease Therapeutics Market Trends

Table 13. Sexually Transmitted Disease Therapeutics Market Drivers

Table 14. Sexually Transmitted Disease Therapeutics Market Challenges

Table 15. Sexually Transmitted Disease Therapeutics Market Restraints

Table 16. Global Sexually Transmitted Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Sexually Transmitted Disease Therapeutics Revenue Share by Players (2019-2024)

Table 18. Global Top Sexually Transmitted Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Therapeutics as of 2023)

Table 19. Global Sexually Transmitted Disease Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Sexually Transmitted Disease Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Sexually Transmitted Disease Therapeutics, Product and Application

Table 23. Global Key Players of Sexually Transmitted Disease Therapeutics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Sexually Transmitted Disease Therapeutics Revenue Share by Application (2019-2024)

Table 31. Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Sexually Transmitted Disease Therapeutics Revenue Share by Application (2025-2030)

Table 33. North America Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Sexually Transmitted Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Sexually Transmitted Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Sexually Transmitted Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Sexually Transmitted Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Sexually Transmitted Disease Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Sexually Transmitted Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Sexually Transmitted Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 65. Abbott Company Details

Table 66. Abbott Business Overview

Table 67. Abbott Sexually Transmitted Disease Therapeutics Product

Table 68. Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 69. Abbott Recent Developments

Table 70. Roche Company Details

Table 71. Roche Business Overview

Table 72. Roche Sexually Transmitted Disease Therapeutics Product

Table 73. Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 74. Roche Recent Developments

Table 75. BD Company Details

Table 76. BD Business Overview

Table 77. BD Sexually Transmitted Disease Therapeutics Product

Table 78. BD Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 79. BD Recent Developments

Table 80. BioMérieux Company Details

Table 81. BioMérieux Business Overview

Table 82. BioMérieux Sexually Transmitted Disease Therapeutics Product

Table 83. BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 84. BioMérieux Recent Developments

Table 85. Bio-Rad Company Details

Table 86. Bio-Rad Business Overview

Table 87. Bio-Rad Sexually Transmitted Disease Therapeutics Product

Table 88. Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 89. Bio-Rad Recent Developments

Table 90. Cepheid Company Details

Table 91. Cepheid Business Overview

Table 92. Cepheid Sexually Transmitted Disease Therapeutics Product

Table 93. Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2019-2024) & (US$ Million)

Table 94. Cepheid Recent Developments

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Sexually Transmitted Disease Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Gonorrhea Features

Figure 4. Syphilis Features

Figure 5. Chlamydia Features

Figure 6. Trichomoniasis Features

Figure 7. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Sexually Transmitted Disease Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Research and Academic Laboratories Case Studies

Figure 12. Others Case Studies

Figure 13. Sexually Transmitted Disease Therapeutics Report Years Considered

Figure 14. Global Sexually Transmitted Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Sexually Transmitted Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Sexually Transmitted Disease Therapeutics Market Share by Region: 2023 VS 2030

Figure 17. Global Sexually Transmitted Disease Therapeutics Market Share by Players in 2023

Figure 18. Global Top Sexually Transmitted Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Therapeutics as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease Therapeutics Revenue in 2023

Figure 20. North America Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

Figure 22. North America Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

Figure 23. North America Sexually Transmitted Disease Therapeutics Market Share by Country (2019-2030)

Figure 24. United States Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Sexually Transmitted Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

Figure 28. Europe Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

Figure 29. Europe Sexually Transmitted Disease Therapeutics Market Share by Country (2019-2030)

Figure 30. Germany Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Sexually Transmitted Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

Figure 38. China Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Sexually Transmitted Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

Figure 41. Asia Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

Figure 42. Asia Sexually Transmitted Disease Therapeutics Market Share by Region (2019-2030)

Figure 43. Japan Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Sexually Transmitted Disease Therapeutics Market Share by Country (2019-2030)

Figure 53. Brazil Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Abbott Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2019-2024)

Figure 60. Roche Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2019-2024)

Figure 61. BD Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2019-2024)

Figure 62. BioMérieux Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2019-2024)

Figure 63. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2019-2024)

Figure 64. Cepheid Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions